Stay updated on LITT with Checkpoint Inhibitor for RGBM Clinical Trial
Sign up to get notified when there's something new on the LITT with Checkpoint Inhibitor for RGBM Clinical Trial page.

Latest updates to the LITT with Checkpoint Inhibitor for RGBM Clinical Trial page
- Check3 days agoChange DetectedStudy status updated to Active, not recruiting with new 2026 dates and revision to v3.3.4. The prior Recruiting status and the study contact details have been removed.SummaryDifference1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedNew: Locations section now includes Ohio as a recruitment site. Removed: Ohio Locations and HHS Vulnerability Disclosure link; page updated to Revision: v3.3.3.SummaryDifference0.2%

- Check53 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedThe government funding lapse notice has been removed from the page. This banner removal does not change the study details, eligibility criteria, or locations listed.SummaryDifference0.3%

- Check74 days agoChange DetectedCore study information, including title, objectives, eligibility criteria, locations, and contacts, remains unchanged; observed differences are limited to minor UI adjustments and an updated last-updated timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check103 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

Stay in the know with updates to LITT with Checkpoint Inhibitor for RGBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LITT with Checkpoint Inhibitor for RGBM Clinical Trial page.